Volume 26, Number 9—September 2020
Synopsis
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020
Table 4
Characteristic | No./total no. (%)† |
|
---|---|---|
Self-reported illness in past 2 mo, n = 39 | Self-reported illness in past 2 wk, n = 13 | |
Sign/symptom | ||
Measured fever | 5/36 (14) | 3/12 (25) |
Subjective fever | 16/37 (43) | 2/13 (15) |
Cough | 15/36 (42) | 6/12 (50) |
Sore throat | 21/38 (55) | 9/13 (69) |
Muscle aches | 10/37 (27) | 2/11 (18) |
Headache | 12/37 (32) | 1/12 (8) |
Shortness of breath | 2/34 (6) | 1/12 (8) |
Vomiting | 3/33 (9) | 1/11 (9) |
Diarrhea | 7/36 (19) | 1/12 (8) |
Fatigue | 16/37 (43) | 3/12 (25) |
Other | 10/30 (33) | 6/10 (60) |
Any coronavirus sign/symptom‡ |
24/39 (62) |
9/13 (69) |
Identified as a person under investigation for COVID-19 signs/symptoms§ | 10/39 (26) | 2/13 (15) |
Sought medical care for illness in past 2 wk | 1/39 (3) | 0/13 (0) |
*All persons who self-reported illness submitted serum and a nasopharyngeal or oropharyngeal swab specimen. COVID-19, coronavirus disease.
†Persons for whom responses were missing were excluded from the numerator and denominator.
‡Measured fever OR subjective fever, cough, or shortness of breath.
§Measured or subjective fever AND shortness of breath or cough.
Page created: May 27, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.